Drug General Information
Drug ID
D04ETV
Former ID
DIB000407
Drug Name
Nemonaxacin
Indication Methicillin-resistant staphylococcus aureus infection [ICD10:B95.62] Phase 3 [524857]
Company
Warner Chilcott plc
Target and Pathway
Target(s) Topoisomerase IV Target Info Modulator
References
Ref 524857ClinicalTrials.gov (NCT02205112) A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAP. U.S. National Institutes of Health.